|
OMIM |
Link |
Information gain |
01 |
|
stature quantitative trait locus 3
|
[NCBI]
|
0.00188466
|
|
|
FSHMD1A
|
[NCBI]
|
0.00164778
|
|
|
HBFQTL4
|
[NCBI]
|
0.00156007
|
|
|
x inactivation, familial skewed, 2
|
[NCBI]
|
0.00146529
|
|
|
alopecia areata 1
|
[NCBI]
|
0.00111462
|
|
|
VDR
|
[NCBI]
|
0.000967264
|
|
|
IS1
|
[NCBI]
|
0.000884307
|
|
|
HBFQTL2
|
[NCBI]
|
0.000808354
|
|
|
epidermolysis bullosa dystrophica, pasini type
|
[NCBI]
|
0.000174316
|
|
|
RA
|
[NCBI]
|
0.000155915
|
|
|
OCRL
|
[NCBI]
|
0.000138296
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
0.000135388
|
|
|
hemophilia a
|
[NCBI]
|
0.000129453
|
|
|
NEPPK
|
[NCBI]
|
0.000112362
|
|
|
pilomatrixoma
|
[NCBI]
|
0.000112362
|
|
|
vitamin d-dependent rickets, type ii
|
[NCBI]
|
0.000101379
|
|
|
alpha-b crystallinopathy
|
[NCBI]
|
0.000100479
|
|
|
neuropathy, ataxia, and retinitis pigmentosa
|
[NCBI]
|
0.000100479
|
|
|
leber optic atrophy
|
[NCBI]
|
9.68065e-05
|
|
|
hypertension, essential
|
[NCBI]
|
9.52073e-05
|
|
|
CRS1
|
[NCBI]
|
8.70599e-05
|
|
|
CCA2
|
[NCBI]
|
8.25124e-05
|
|
|
LDLR
|
[NCBI]
|
7.87059e-05
|
|
|
EGF
|
[NCBI]
|
7.71078e-05
|
|
|
SXI1
|
[NCBI]
|
7.55122e-05
|
|
|
PIL
|
[NCBI]
|
7.55122e-05
|
|
|
NFNS
|
[NCBI]
|
7.55122e-05
|
|
|
HCHWAD
|
[NCBI]
|
7.26973e-05
|
|
|
SLE
|
[NCBI]
|
7.20276e-05
|
|
|
GGM
|
[NCBI]
|
7.02011e-05
|
|
|
fabry disease
|
[NCBI]
|
6.73647e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
6.59261e-05
|
|
|
EDMD2
|
[NCBI]
|
6.59261e-05
|
|
|
ARH
|
[NCBI]
|
6.59261e-05
|
|
|
SPG2
|
[NCBI]
|
6.59261e-05
|
|
|
LGMD2D
|
[NCBI]
|
6.4066e-05
|
|
|
APOB
|
[NCBI]
|
5.95367e-05
|
|
|
GRTH
|
[NCBI]
|
5.92851e-05
|
|
|
vitamin d-dependent rickets, type i
|
[NCBI]
|
5.7901e-05
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
5.7901e-05
|
|
|
pituitary dwarfism iii
|
[NCBI]
|
5.66008e-05
|
|
|
alcohol dependence
|
[NCBI]
|
5.66008e-05
|
|
|
pituitary dwarfism i
|
[NCBI]
|
5.66008e-05
|
|
|
PLP1
|
[NCBI]
|
5.63551e-05
|
|
|
BCR
|
[NCBI]
|
5.62567e-05
|
|
|
DKC
|
[NCBI]
|
5.53752e-05
|
|
|
REN
|
[NCBI]
|
5.48398e-05
|
|
|
SMA2
|
[NCBI]
|
5.42164e-05
|
|
|
uridine 5-prime monophosphate hydrolase deficiency, hemolytic anemia due to
|
[NCBI]
|
5.42164e-05
|
|
|
EBR1
|
[NCBI]
|
5.42164e-05
|
|
|
CDPX2
|
[NCBI]
|
5.42164e-05
|
|
|
thyroid hormonogenesis, genetic defect in, 2a
|
[NCBI]
|
5.31176e-05
|
|
|
LFS1
|
[NCBI]
|
5.20731e-05
|
|
|
NGFB
|
[NCBI]
|
5.14955e-05
|
|
|
DAR
|
[NCBI]
|
5.0128e-05
|
|
|
gaucher disease, type iii
|
[NCBI]
|
5.0128e-05
|
|
|
diabetes insipidus, nephrogenic, x-linked
|
[NCBI]
|
4.83486e-05
|
|
|
immunodeficiency-centromeric instability-facial anomalies syndrome
|
[NCBI]
|
4.83486e-05
|
|
|
COL4A5
|
[NCBI]
|
4.69339e-05
|
|
|
HBFQTL1
|
[NCBI]
|
4.5937e-05
|
|
|
XPA
|
[NCBI]
|
4.5937e-05
|
|
|
ALPPL2
|
[NCBI]
|
4.58533e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase/delta-isomerase, type i
|
[NCBI]
|
4.58533e-05
|
|
|
graves disease
|
[NCBI]
|
4.44735e-05
|
|
|
HEMB
|
[NCBI]
|
4.40661e-05
|
|
|
AVPR2
|
[NCBI]
|
4.40234e-05
|
|
|
thyroid carcinoma, papillary
|
[NCBI]
|
4.37793e-05
|
|
|
EDMD
|
[NCBI]
|
4.37793e-05
|
|
|
hypophosphatasia, infantile
|
[NCBI]
|
4.37793e-05
|
|
|
TYR
|
[NCBI]
|
4.28656e-05
|
|
|
HBB
|
[NCBI]
|
4.14199e-05
|
|
|
MADD
|
[NCBI]
|
4.12193e-05
|
|
|
drug metabolism, poor, cyp2d6-related
|
[NCBI]
|
4.12193e-05
|
|
|
MTATP6
|
[NCBI]
|
4.01444e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
3.94938e-05
|
|
|
CYP2D6
|
[NCBI]
|
3.79217e-05
|
|
|
lactase persistence
|
[NCBI]
|
3.7907e-05
|
|
|
LPL
|
[NCBI]
|
3.7512e-05
|
|
|
SLC6A2
|
[NCBI]
|
3.74176e-05
|
|
|
CTSE
|
[NCBI]
|
3.74176e-05
|
|
|
DRD2
|
[NCBI]
|
3.70617e-05
|
|
|
LHCGR
|
[NCBI]
|
3.70617e-05
|
|
|
APOC1
|
[NCBI]
|
3.64943e-05
|
|
|
CHM
|
[NCBI]
|
3.59744e-05
|
|
|
CALCR
|
[NCBI]
|
3.56462e-05
|
|
|
ND
|
[NCBI]
|
3.46426e-05
|
|
|
ABCB4
|
[NCBI]
|
3.34518e-05
|
|
|
SELE
|
[NCBI]
|
3.34518e-05
|
|
|
SMA1
|
[NCBI]
|
3.33982e-05
|
|
|
LRRN5
|
[NCBI]
|
3.31253e-05
|
|
|
C3ORF35
|
[NCBI]
|
3.31253e-05
|
|
|
transfer rna arginine
|
[NCBI]
|
3.31253e-05
|
|
|
TTC21A
|
[NCBI]
|
3.31253e-05
|
|
|
JK
|
[NCBI]
|
3.28128e-05
|
|
|
AMY1A
|
[NCBI]
|
3.22109e-05
|
|
|
galactosemia
|
[NCBI]
|
3.14921e-05
|
|
|
ACADM
|
[NCBI]
|
3.14465e-05
|
|
|
HGPS
|
[NCBI]
|
3.11334e-05
|
|
|
SLC2A1
|
[NCBI]
|
3.11035e-05
|
|
|
ACH
|
[NCBI]
|
3.04365e-05
|
|
|
IBD1
|
[NCBI]
|
3.04365e-05
|
|
|
APOA1
|
[NCBI]
|
3.02722e-05
|
|
|
F12
|
[NCBI]
|
3.0104e-05
|
|
|
IRF1
|
[NCBI]
|
3.0104e-05
|
|
|
KLK3
|
[NCBI]
|
2.90813e-05
|
|
|
MEN2A
|
[NCBI]
|
2.88032e-05
|
|
|
ALD
|
[NCBI]
|
2.83664e-05
|
|
|
SCA1
|
[NCBI]
|
2.81896e-05
|
|
|
RBP3
|
[NCBI]
|
2.58805e-05
|
|
|
neuroblastoma-amplified gene
|
[NCBI]
|
2.57128e-05
|
|
|
CPNE5
|
[NCBI]
|
2.57128e-05
|
|
|
CHRM4
|
[NCBI]
|
2.57128e-05
|
|
|
ZNF34
|
[NCBI]
|
2.57128e-05
|
|
|
TNF
|
[NCBI]
|
2.5574e-05
|
|
|
ESR1
|
[NCBI]
|
2.54427e-05
|
|
|
PCNA
|
[NCBI]
|
2.53761e-05
|
|
|
APOC2
|
[NCBI]
|
2.46988e-05
|
|
|
RET
|
[NCBI]
|
2.44895e-05
|
|
|
LPI
|
[NCBI]
|
2.41712e-05
|
|
|
CD
|
[NCBI]
|
2.39344e-05
|
|
|
CPI
|
[NCBI]
|
2.39344e-05
|
|
|
EPO
|
[NCBI]
|
2.33376e-05
|
|
|
GFAP
|
[NCBI]
|
2.32797e-05
|
|
|
GMPS
|
[NCBI]
|
2.29219e-05
|
|
|
MYL4
|
[NCBI]
|
2.29219e-05
|
|
|
DNASE1L2
|
[NCBI]
|
2.29219e-05
|
|
|
TPSD1
|
[NCBI]
|
2.29219e-05
|
|
|
APRT
|
[NCBI]
|
2.27989e-05
|
|
|
DES
|
[NCBI]
|
2.26901e-05
|
|
|
EIG
|
[NCBI]
|
2.25813e-05
|
|
|
FRDA
|
[NCBI]
|
2.25813e-05
|
|
|
VIP
|
[NCBI]
|
2.24798e-05
|
|
|
HBA2
|
[NCBI]
|
2.24667e-05
|
|
|
AD
|
[NCBI]
|
2.24168e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
2.23664e-05
|
|
|
L1CAM
|
[NCBI]
|
2.22463e-05
|
|
|
AHO
|
[NCBI]
|
2.17384e-05
|
|
|
BST1
|
[NCBI]
|
2.11133e-05
|
|
|
CRSP2
|
[NCBI]
|
2.11133e-05
|
|
|
F8A
|
[NCBI]
|
2.11133e-05
|
|
|
RAD23A
|
[NCBI]
|
2.11133e-05
|
|
|
GORASP1
|
[NCBI]
|
2.11133e-05
|
|
|
HMBS
|
[NCBI]
|
2.08897e-05
|
|
|
PWS
|
[NCBI]
|
2.00045e-05
|
|
|
hypercholesterolemia, autosomal dominant
|
[NCBI]
|
1.99927e-05
|
|
|
PGK1
|
[NCBI]
|
1.97737e-05
|
|
|
CDR1
|
[NCBI]
|
1.97713e-05
|
|
|
NCK1
|
[NCBI]
|
1.97713e-05
|
|
|
PPP2R1B
|
[NCBI]
|
1.97713e-05
|
|
|
HRC
|
[NCBI]
|
1.97713e-05
|
|
|
PLA2G1B
|
[NCBI]
|
1.97713e-05
|
|
|
BRSK2
|
[NCBI]
|
1.97713e-05
|
|
|
ETFB
|
[NCBI]
|
1.97713e-05
|
|
|
CALM2
|
[NCBI]
|
1.97713e-05
|
|
|
methemoglobinemia due to deficiency of methemoglobin reductase
|
[NCBI]
|
1.94445e-05
|
|
|
MTND4
|
[NCBI]
|
1.92841e-05
|
|
|
HFE
|
[NCBI]
|
1.88786e-05
|
|
|
TH
|
[NCBI]
|
1.87657e-05
|
|
|
XCE
|
[NCBI]
|
1.87041e-05
|
|
|
ANXA8
|
[NCBI]
|
1.87041e-05
|
|
|
TPSB2
|
[NCBI]
|
1.87041e-05
|
|
|
RRM1
|
[NCBI]
|
1.87041e-05
|
|
|
ATP1A3
|
[NCBI]
|
1.87041e-05
|
|
|
ARF4
|
[NCBI]
|
1.87041e-05
|
|
|
ADRA1A
|
[NCBI]
|
1.87041e-05
|
|
|
IGSF1
|
[NCBI]
|
1.87041e-05
|
|
|
TCP1
|
[NCBI]
|
1.87041e-05
|
|
|
HBA1
|
[NCBI]
|
1.85373e-05
|
|
|
DMD
|
[NCBI]
|
1.83698e-05
|
|
|
MPO
|
[NCBI]
|
1.82249e-05
|
|
|
INS
|
[NCBI]
|
1.80186e-05
|
|
|
G6PD
|
[NCBI]
|
1.79701e-05
|
|
|
RAD23B
|
[NCBI]
|
1.78184e-05
|
|
|
ROM1
|
[NCBI]
|
1.78184e-05
|
|
|
NPY1R
|
[NCBI]
|
1.78184e-05
|
|
|
TPP2
|
[NCBI]
|
1.78184e-05
|
|
|
VAMP1
|
[NCBI]
|
1.78184e-05
|
|
|
MYL3
|
[NCBI]
|
1.78184e-05
|
|
|
PMD
|
[NCBI]
|
1.71633e-05
|
|
|
SLC4A2
|
[NCBI]
|
1.70618e-05
|
|
|
TPSAB1
|
[NCBI]
|
1.70618e-05
|
|
|
SLC7A7
|
[NCBI]
|
1.70618e-05
|
|
|
ACTN3
|
[NCBI]
|
1.70618e-05
|
|
|
HSD17B1
|
[NCBI]
|
1.70618e-05
|
|
|
PTPRG
|
[NCBI]
|
1.70618e-05
|
|
|
CPA1
|
[NCBI]
|
1.70618e-05
|
|
|
CSRP1
|
[NCBI]
|
1.70618e-05
|
|
|
SHANK3
|
[NCBI]
|
1.70618e-05
|
|
|
SLC39A4
|
[NCBI]
|
1.70618e-05
|
|
|
ADRA2A
|
[NCBI]
|
1.70618e-05
|
|
|
CKB
|
[NCBI]
|
1.70618e-05
|
|
|
GIPR
|
[NCBI]
|
1.70618e-05
|
|
|
GLRA2
|
[NCBI]
|
1.70618e-05
|
|
|
complement component 8 deficiency, type ii
|
[NCBI]
|
1.70618e-05
|
|
|
MOS
|
[NCBI]
|
1.70618e-05
|
|
|
CCK
|
[NCBI]
|
1.64516e-05
|
|
|
GBA
|
[NCBI]
|
1.6434e-05
|
|
|
NT5C3
|
[NCBI]
|
1.64017e-05
|
|
|
MTRR
|
[NCBI]
|
1.64017e-05
|
|
|
BMP5
|
[NCBI]
|
1.64017e-05
|
|
|
COL2A1
|
[NCBI]
|
1.59798e-05
|
|
|
FCER1A
|
[NCBI]
|
1.58165e-05
|
|
|
ITIH1
|
[NCBI]
|
1.58165e-05
|
|
|
ZFX
|
[NCBI]
|
1.58165e-05
|
|
|
CSPG2
|
[NCBI]
|
1.52911e-05
|
|
|
glutathionuria
|
[NCBI]
|
1.52911e-05
|
|
|
CD38
|
[NCBI]
|
1.52911e-05
|
|
|
LAMC1
|
[NCBI]
|
1.52911e-05
|
|
|
GYS1
|
[NCBI]
|
1.52911e-05
|
|
|
PKP1
|
[NCBI]
|
1.52911e-05
|
|
|
KRT16
|
[NCBI]
|
1.52911e-05
|
|
|
Ss
|
[NCBI]
|
1.52911e-05
|
|
|
LAMB1
|
[NCBI]
|
1.52911e-05
|
|
|
BMP6
|
[NCBI]
|
1.52911e-05
|
|
|
TOP2A
|
[NCBI]
|
1.48147e-05
|
|
|
HBE1
|
[NCBI]
|
1.48147e-05
|
|
|
LMNA
|
[NCBI]
|
1.45527e-05
|
|
|
IVL
|
[NCBI]
|
1.43789e-05
|
|
|
OCRL
|
[NCBI]
|
1.43789e-05
|
|
|
CALML3
|
[NCBI]
|
1.43789e-05
|
|
|
CYP2E
|
[NCBI]
|
1.43789e-05
|
|
|
CCKAR
|
[NCBI]
|
1.39776e-05
|
|
|
NDN
|
[NCBI]
|
1.39776e-05
|
|
|
ATP1A1
|
[NCBI]
|
1.39776e-05
|
|
|
GH1
|
[NCBI]
|
1.39188e-05
|
|
|
YY1
|
[NCBI]
|
1.36058e-05
|
|
|
PFKL
|
[NCBI]
|
1.36058e-05
|
|
|
BCKDHA
|
[NCBI]
|
1.36058e-05
|
|
|
SLC5A1
|
[NCBI]
|
1.36058e-05
|
|
|
AVP
|
[NCBI]
|
1.33764e-05
|
|
|
AGL
|
[NCBI]
|
1.32596e-05
|
|
|
CRYBA1
|
[NCBI]
|
1.32596e-05
|
|
|
TAP1
|
[NCBI]
|
1.32596e-05
|
|
|
CRYBB2
|
[NCBI]
|
1.32596e-05
|
|
|
SGCA
|
[NCBI]
|
1.29357e-05
|
|
|
CALM1
|
[NCBI]
|
1.29357e-05
|
|
|
BWS
|
[NCBI]
|
1.27066e-05
|
|
|
CAST
|
[NCBI]
|
1.26316e-05
|
|
|
POLD1
|
[NCBI]
|
1.26316e-05
|
|
|
CYP11A1
|
[NCBI]
|
1.26316e-05
|
|
|
FSHB
|
[NCBI]
|
1.26316e-05
|
|
|
GLDC
|
[NCBI]
|
1.26316e-05
|
|
|
PRKCG
|
[NCBI]
|
1.26316e-05
|
|
|
TSHB
|
[NCBI]
|
1.26316e-05
|
|
|
AMY2A
|
[NCBI]
|
1.2345e-05
|
|
|
ADRB3
|
[NCBI]
|
1.2074e-05
|
|
|
PI
|
[NCBI]
|
1.19208e-05
|
|
|
MAN2B1
|
[NCBI]
|
1.18172e-05
|
|
|
TKT
|
[NCBI]
|
1.18172e-05
|
|
|
CYP2C19
|
[NCBI]
|
1.18172e-05
|
|
|
C9
|
[NCBI]
|
1.15731e-05
|
|
|
3-@beta-hydroxysteroid dehydrogenase, type ii, deficiency of
|
[NCBI]
|
1.15731e-05
|
|
|
DRD3
|
[NCBI]
|
1.15731e-05
|
|
|
PYGM
|
[NCBI]
|
1.15731e-05
|
|
|
NME1
|
[NCBI]
|
1.15731e-05
|
|
|
IAPP
|
[NCBI]
|
1.13441e-05
|
|
|
CR1
|
[NCBI]
|
1.13406e-05
|
|
|
SLC5A5
|
[NCBI]
|
1.13406e-05
|
|
|
NR3C2
|
[NCBI]
|
1.13406e-05
|
|
|
CAT
|
[NCBI]
|
1.12631e-05
|
|
|
UCP1
|
[NCBI]
|
1.1196e-05
|
|
|
PLOD1
|
[NCBI]
|
1.11188e-05
|
|
|
XPC
|
[NCBI]
|
1.11188e-05
|
|
|
TK1
|
[NCBI]
|
1.11188e-05
|
|
|
RHD
|
[NCBI]
|
1.11188e-05
|
|
|
COL4A1
|
[NCBI]
|
1.09066e-05
|
|
|
PMM2
|
[NCBI]
|
1.09066e-05
|
|
|
VAMP2
|
[NCBI]
|
1.07034e-05
|
|
|
AACT
|
[NCBI]
|
1.07034e-05
|
|
|
CRYAB
|
[NCBI]
|
1.05084e-05
|
|
|
CD8A
|
[NCBI]
|
1.01408e-05
|
|
|
AHSG
|
[NCBI]
|
1.01408e-05
|
|
|
GSTM1
|
[NCBI]
|
1.01408e-05
|
|
|
TSD
|
[NCBI]
|
1.00414e-05
|
|
|
NGFR
|
[NCBI]
|
1.00412e-05
|
|
|
AICDA
|
[NCBI]
|
9.9671e-06
|
|
|
NPC1
|
[NCBI]
|
9.9671e-06
|
|
|
PROP1
|
[NCBI]
|
9.9671e-06
|
|
|
XPA
|
[NCBI]
|
9.79959e-06
|
|
|
NPPA
|
[NCBI]
|
9.64324e-06
|
|
|
CETP
|
[NCBI]
|
9.63785e-06
|
|
|
ALPL
|
[NCBI]
|
9.63785e-06
|
|
|
ALB
|
[NCBI]
|
9.34379e-06
|
|
|
MTND5
|
[NCBI]
|
9.33023e-06
|
|
|
MFS
|
[NCBI]
|
9.23114e-06
|
|
|
complement component 6 deficiency
|
[NCBI]
|
9.18373e-06
|
|
|
GSN
|
[NCBI]
|
9.04174e-06
|
|
|
APOH
|
[NCBI]
|
9.04174e-06
|
|
|
AS
|
[NCBI]
|
9.0005e-06
|
|
|
BGLAP
|
[NCBI]
|
8.95057e-06
|
|
|
RARA
|
[NCBI]
|
8.904e-06
|
|
|
CREM
|
[NCBI]
|
8.904e-06
|
|
|
APP
|
[NCBI]
|
8.81405e-06
|
|
|
glycogen storage disease ixa
|
[NCBI]
|
8.77027e-06
|
|
|
MTCO2
|
[NCBI]
|
8.77027e-06
|
|
|
CST3
|
[NCBI]
|
8.64036e-06
|
|
|
NF1
|
[NCBI]
|
8.50563e-06
|
|
|
GLA
|
[NCBI]
|
8.27161e-06
|
|
|
TPI1
|
[NCBI]
|
8.27161e-06
|
|
|
GAA
|
[NCBI]
|
8.27161e-06
|
|
|
PKLR
|
[NCBI]
|
8.15512e-06
|
|
|
fucosidosis
|
[NCBI]
|
8.0416e-06
|
|
|
ADA
|
[NCBI]
|
7.89349e-06
|
|
|
LPA
|
[NCBI]
|
7.71753e-06
|
|
|
wolman disease
|
[NCBI]
|
7.71753e-06
|
|
|
ornithine aminotransferase deficiency
|
[NCBI]
|
7.61461e-06
|
|
|
transcobalamin ii deficiency
|
[NCBI]
|
7.61461e-06
|
|
|
AMACR
|
[NCBI]
|
7.51407e-06
|
|
|
factor x deficiency
|
[NCBI]
|
7.4158e-06
|
|
|
RHCE
|
[NCBI]
|
7.4158e-06
|
|
|
COL7A1
|
[NCBI]
|
7.4158e-06
|
|
|
C4A
|
[NCBI]
|
7.4158e-06
|
|
|
ERBB2
|
[NCBI]
|
7.4158e-06
|
|
|
HS
|
[NCBI]
|
7.22574e-06
|
|
|
MBP
|
[NCBI]
|
7.13359e-06
|
|
|
IGHG1
|
[NCBI]
|
7.04376e-06
|
|
|
PTH
|
[NCBI]
|
7.0319e-06
|
|
|
GALT
|
[NCBI]
|
6.95561e-06
|
|
|
ALAD
|
[NCBI]
|
6.86927e-06
|
|
|
OTC
|
[NCBI]
|
6.5407e-06
|
|
|
IGF2
|
[NCBI]
|
6.3857e-06
|
|
|
ELN
|
[NCBI]
|
6.3857e-06
|
|
|
TP53
|
[NCBI]
|
6.3621e-06
|
|
|
SPTA1
|
[NCBI]
|
6.23638e-06
|
|
|
A2M
|
[NCBI]
|
6.23638e-06
|
|
|
HBG2
|
[NCBI]
|
6.16373e-06
|
|
|
SLC18A2
|
[NCBI]
|
6.16373e-06
|
|
|
CF
|
[NCBI]
|
6.09801e-06
|
|
|
XIST
|
[NCBI]
|
6.09237e-06
|
|
|
TTR
|
[NCBI]
|
6.07323e-06
|
|
|
ITGB3
|
[NCBI]
|
5.95335e-06
|
|
|
CTNNB1
|
[NCBI]
|
5.81904e-06
|
|
|
ARSA
|
[NCBI]
|
5.56348e-06
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
5.56348e-06
|
|
|
GHR
|
[NCBI]
|
5.56295e-06
|
|
|
THRB
|
[NCBI]
|
5.38233e-06
|
|
|
SLC4A1
|
[NCBI]
|
5.38233e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
5.29843e-06
|
|
|
SNCA
|
[NCBI]
|
5.20942e-06
|
|
|
IDUA
|
[NCBI]
|
5.04415e-06
|
|
|
BTK
|
[NCBI]
|
5.04415e-06
|
|
|
WAS
|
[NCBI]
|
5.01691e-06
|
|
|
MTHFR
|
[NCBI]
|
4.88595e-06
|
|
|
HBG1
|
[NCBI]
|
4.83471e-06
|
|
|
MPZ
|
[NCBI]
|
4.63674e-06
|
|
|
MEN1
|
[NCBI]
|
4.63674e-06
|
|
|
UCP3
|
[NCBI]
|
4.58892e-06
|
|
|
TF
|
[NCBI]
|
4.58098e-06
|
|
|
LIPC
|
[NCBI]
|
4.1023e-06
|
|
|
GNAS
|
[NCBI]
|
4.02087e-06
|
|
|
PTGS2
|
[NCBI]
|
3.90239e-06
|
|
|
BCHE
|
[NCBI]
|
3.84986e-06
|
|
|
CJD
|
[NCBI]
|
3.79948e-06
|
|
|
ASS
|
[NCBI]
|
3.75086e-06
|
|
|
PKD1
|
[NCBI]
|
3.71407e-06
|
|
|
FBN1
|
[NCBI]
|
3.57109e-06
|
|
|
COL1A1
|
[NCBI]
|
3.57109e-06
|
|
|
VIM
|
[NCBI]
|
3.36833e-06
|
|
|
ESD
|
[NCBI]
|
3.33582e-06
|
|
|
DHFR
|
[NCBI]
|
3.08626e-06
|
|
|
INSR
|
[NCBI]
|
2.88741e-06
|
|
|
RHO
|
[NCBI]
|
2.83269e-06
|
|
|
TYMS
|
[NCBI]
|
2.73242e-06
|
|
|
RB1
|
[NCBI]
|
2.70058e-06
|
|
|
DDC
|
[NCBI]
|
2.67493e-06
|
|
|
ABCB1
|
[NCBI]
|
2.62438e-06
|
|
|
F3
|
[NCBI]
|
2.53783e-06
|
|
|
GC
|
[NCBI]
|
2.40855e-06
|
|
|
COMT
|
[NCBI]
|
2.38957e-06
|
|
|
LEP
|
[NCBI]
|
2.31837e-06
|
|
|
HD
|
[NCBI]
|
2.26741e-06
|
|
|
SLC2A4
|
[NCBI]
|
2.2529e-06
|
|
|
FGFR2
|
[NCBI]
|
2.21024e-06
|
|
|
SHBG
|
[NCBI]
|
2.14844e-06
|
|
|
CASR
|
[NCBI]
|
2.02761e-06
|
|
|
PPARA
|
[NCBI]
|
1.99416e-06
|
|
|
ACE
|
[NCBI]
|
1.90141e-06
|
|
|
PMP22
|
[NCBI]
|
1.6703e-06
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
1.60597e-06
|
|
|
phenylketonuria
|
[NCBI]
|
1.39722e-06
|
|
|
PRNP
|
[NCBI]
|
1.31499e-06
|
|
|
GAPDH
|
[NCBI]
|
1.29865e-06
|
|
|
GRP
|
[NCBI]
|
1.24954e-06
|
|
|
SLC6A3
|
[NCBI]
|
1.18221e-06
|
|
|
CYP1A1
|
[NCBI]
|
1.09617e-06
|
|
|
PLG
|
[NCBI]
|
8.7922e-07
|
|
|
APOE
|
[NCBI]
|
8.74175e-07
|
|
|
TLR2
|
[NCBI]
|
7.85533e-07
|
|
|
PNMT
|
[NCBI]
|
2.76105e-07
|
|
|
MBL2
|
[NCBI]
|
2.45956e-07
|
|
|
STAR
|
[NCBI]
|
2.33687e-07
|
|
|
SOD2
|
[NCBI]
|
1.94597e-07
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
1.88664e-07
|
|
|
MG
|
[NCBI]
|
9.78364e-08
|
|
|
AR
|
[NCBI]
|
5.53356e-08
|
|
|
HP
|
[NCBI]
|
3.99019e-08
|
|
|
MB
|
[NCBI]
|
3.16196e-08
|
|
|
TPO
|
[NCBI]
|
5.92196e-09
|
|
|
LCAT
|
[NCBI]
|
3.55077e-09
|
|
|
APC
|
[NCBI]
|
1.13642e-09
|
|
|
PGR
|
[NCBI]
|
6.36293e-10
|
|
|
CD
|
[NCBI]
|
8.38587e-11
|
|